The Filing Desk

Biodesix vs Exagen

Biodesix BDSX · Exagen XGN · Health Care Services

Biodesix reported revenue of $88 million in fiscal 2025, 1.3 times Exagen's $67 million in fiscal 2025. Biodesix's revenue grew 24.1% in its latest year, and Exagen's grew 19.6%. Biodesix had an operating margin of -31.5%, against -21.1% at Exagen. Free cash flow was −$24 million at Biodesix and −$14 million at Exagen.

Side by side

BiodesixExagen
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$88M$67M
Revenue growth24.1%19.6%
Revenue growth a year, last 5 years14.2%9.7%
Gross margin—58.3%
Operating margin−31.5%−21.1%
Net margin−39.9%−30.0%
Free cash flow−$24M−$14M
Free cash flow margin−26.6%−21.4%
Return on capital−69.7%−115.0%
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count16.7%18.4%
Last close$8.30$3.80
P/E at the last close——
Insider trades, last 12 monthsbought $3.1 million, sold $104,401sold $252,640
Piotroski F-score3 of 83 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
BiodesixExagen
Operating margin
Percent of revenue
BiodesixExagen
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
BiodesixExagen

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Biodesix and Exagen pages.